Remove 2017 Remove Competition Remove Healthcare Provider
article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO). To illustrate, let’s take the example of protectionist policies. References: 1.

article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Integrating Digital Marketing in Pharmaceutical Industry: Unlocking New Opportunities for Patient Outreach and Engagement

Pharma Marketing Network

Digital marketing provides a range of innovative tools and techniques for reaching and engaging patients, healthcare providers, and other key decision-makers. 2017, May 3). References: 1. Digital Marketing in the Pharmaceutical Industry: The State of Play. 2020, June 10). ePharma Summit. Razorfish Health.

article thumbnail

HCP Engagement Strategies for the Digital Age

LEVO Health

One of the most pivotal aspects of doing business in the healthcare industry is targeting and engaging healthcare providers (HCPs). Although healthcare providers are now more accessible than ever (thanks to the internet), they are also more inundated with information. Expanding on the Digital Landscape.

article thumbnail

Endovascular Med Device Sales With Michael Clark

Evolve Your Success

Yet, amidst the chaos, he highlights the importance of building relationships with healthcare providers and executing a robust business plan. You want to be respectful of what they’re trying to do for the healthcare providers and you want to support them. About in 2017, I started putting feelers out.

Sales 147
article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years. The same can be said for the US. of adults were overweight, 42.4% were obese, and 9.2% had severe obesity.

Medical 105